14,824 Views
•
12:40 min
•
December 07, 2014
DOI:
Summary
Automatically generated
Emergence of genetic resistance against kinase inhibitor therapy poses significant challenge for effective cancer therapy. Identification and characterization of resistant mutations against a newly developed drug helps in better clinical management and next generation drug design. Here, we describe our protocol for in vitro screening and validation of resistant mutations.
Related Videos
09:38
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Related Videos
8741 Views
07:42
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Related Videos
7893 Views
10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Related Videos
8202 Views
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Related Videos
5951 Views
13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Related Videos
7806 Views
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Related Videos
18082 Views
14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Related Videos
3140 Views
09:33
Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Related Videos
1049 Views
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Related Videos
10512 Views
08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Related Videos
9052 Views
Read Article
Cite this Article
Kesarwani, M., Huber, E., Kincaid, Z., Azam, M. A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors. J. Vis. Exp. (94), e51984, doi:10.3791/51984 (2014).
Copy